|
Complement C3dg-mediated erythrophagocytosis: implications for paroxysmal nocturnal hemoglobinuria
|
Jun 2015
|
Blood
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
How I Treat Paroxysmal nocturnal hemoglobinuria
|
Jan 2021
|
Blood
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Rabbit antithymocyte globulin and cyclosporine as first-line therapy for children with acquired aplastic anemia
|
Jan 2013
|
Blood
|
aplastic anemia
|
|
"Moderate" dose cyclophosphamide for severe aplastic anemia has significant toxicity and does not prevent relapse and clonal evolution.
|
Sep 2014
|
Blood
|
aplastic anemia
|
|
Comparison of the efficacy of rabbit and horse antithymocyte globulin for the treatment of severe aplastic anemia in children
|
Jan 2013
|
Blood
|
aplastic anemia
|
|
A novel histone deacetylase inhibitor Chidamide induces G0/G1 arrest and apoptosis in myelodysplastic syndromes
|
Oct 2016
|
Biomed Pharmacother
|
myelodysplastic syndromes (MDS)
|
|
Diagnosis of paroxysmal nocturnal hemoglobinuria in peripheral blood and bone marrow with six-color flow cytometry.
|
Feb 2012
|
Biomark Med
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Emerging Therapeutics for the Control of Chronic Graft-versus-Host Disease
|
Jan 2018
|
Biology of Blood and Marrow Transportation
|
graft versus host disease (GVHD)
|
|
The case for upfront HLA-matched unrelated donor HCT as a curative option for adult acquired severe aplastic anemia: Upfront MUD HCT for adult severe aplastic anemia
|
May 2019
|
Biology of Blood and Marrow Transplantation: Journal of the American Society of Blood and Marrow Transplantation
|
aplastic anemia
|
|
Impact of CD34 Cell Dose and Conditioning Regimen on Outcomes after Haploidentical Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Relapsed/Refractory Severe Aplastic Anemia
|
Dec 2020
|
Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation
|
aplastic anemia
|
